EUVIMEDEUVIMED entdecken
Crossref

Effects of escitalopram on resting-state functional connectivity in comorbid depressive and anxious adolescents

Jiyoon Shin, Kyung Hwa Lee, Jae-Won Kim

Journal of Affective Disorders · 2026-07 · 405 · 121567

DOI: 10.1016/j.jad.2026.121567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-07. Verfasst von Jiyoon Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Republic of Korea; Division of Chi…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Escitalopram, Amygdala, Hippocampus. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Korea Ministry of Science ICT and Future Planning, Korea Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Given that anxiety is highly comorbid in depressive adolescents, understanding the neural pathways underlying concurrent depression and anxiety could provide potential targets for treatment. We aimed to investigate treatment trajectories for depression and anxiety, and their relationships with neural circuits in the amygdala and hippocampus. METHODS Major depressive disorder (MDD) adolescents and healthy controls were recruited. MDD participants administered escitalopram for eight weeks. Pre- and post-treatment resting-state functional magnetic resonance imaging scans were performed. We investigated treatment trajectories of MDD adolescents (n = 59) considering both depression and anxiety assessed by the Children's Depression Inventory and Screen for Child Anxiety Related Emotional Disorders, respectively. We examined the treatment effect on resting-state functional connectivity (RSFC) of the amygdala and hippocampus across trajectory groups compared these with RSFC patterns in controls (n = 43). RESULTS We identified three treatment trajectory groups: fast-decreasing (FDG, n = 21), no change (NCG, n = 15), and slow-decreasing group (SDG, n = 23). The longitudinal treatment effects on RSFC were pronounced in the FDG. FDG presented decreasing patterns of amygdala RSFC with the post- and precentral gyri, supplementary motor area, and calcarine gyrus. Conversely, the amygdala RSFCs in the middle frontal gyrus and inferior parietal lobule exhibited increasing trends in FDG after treatment. Compared to FDG, SDG showed different patterns of amygdala RSFC, and the amygdala RSFCs of the NCG and healthy controls did not change after treatment. CONCLUSION Longitudinal amygdala RSFC changes following treatment may vary among depressive and anxious adolescents. Neural biomarkers may underlie diverse treatment trajectories, offering potential avenues for targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderEscitalopramAmygdalaHippocampusAnxiety DisordersAntidepressive Agents, Second-GenerationSelective Serotonin Reuptake InhibitorsCitalopramHumansAdolescentMagnetic Resonance ImagingFemaleMaleNeural PathwaysComorbidity

Stichwörter der Autor:innen

AdolescentAnxietyDepressionEscitalopramResting state functional magnetic resonance imagingSerotonin reuptake inhibitor

Substanzen

EscitalopramAntidepressive Agents, Second-GenerationSelective Serotonin Reuptake InhibitorsCitalopram

Autor:innen und Institutionen

  • Department of Psychiatry, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Republic of Korea; Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National…
  • Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: kimjw412@snu.ac.…

Förderung

  • Korea Health Industry Development Institute
  • Korea Ministry of Science ICT and Future Planning
  • Korea Ministry of Health and Welfare
  • National Research Foundation of Korea
  • Seoul National University
  • Ministry of Science ICT and Future Planning

Zitieren

APA

Shin, J., Lee, K. H., & Kim, J. W. (2026). Effects of escitalopram on resting-state functional connectivity in comorbid depressive and anxious adolescents. Journal of Affective Disorders, 405, 121567. https://doi.org/10.1016/j.jad.2026.121567

Vancouver

Shin J, Lee KH, Kim JW. Effects of escitalopram on resting-state functional connectivity in comorbid depressive and anxious adolescents. Journal of Affective Disorders. 2026;405:121567. doi:10.1016/j.jad.2026.121567

BibTeX
@article{Shin2026,
  author = {Shin, Jiyoon and Lee, Kyung Hwa and Kim, Jae-Won},
  title = {Effects of escitalopram on resting-state functional connectivity in comorbid depressive and anxious adolescents},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {405},
  pages = {121567},
  doi = {10.1016/j.jad.2026.121567}
}
Kostenlos starten →